- EFTR Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
eFFECTOR Therapeutics (EFTR) 8-K9 Aug 22Presented positive interim results at ASCO 2022 from ongoing zotatifin Phase 1/2 dose escalation and expansion trialFinancial data
Company Profile